Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 12 Ovarian Neoplasms 11 Fallopian Tube Neoplasms 10 Carcinoma, Non-Small-Cell Lung 7 Pancreatic Neoplasms 5 Brenner Tumor 5 Lung Neoplasms 4 Endometrial Neoplasms 4 Uterine Cervical Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Carcinoma 3 Adenocarcinoma of Lung 3 Oropharyngeal Neoplasms 2 Neurotoxicity Syndromes 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Carcinosarcoma 2 Carcinoma, Transitional Cell 2 Vomiting 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Recurrent Uterine Corpus Carcinoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Cancer Resectable 1 Pancreatic Adenocarcinoma 1 Pancreas Adenocarcinoma 1 Pain 1 Ovarian Germ Cell Cancer 1

Interventions

Taxes 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Gemcitabine 1 Fluorouracil 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pancreatic Cancer Resectable × Taxes × Clear all

NCT07155629 2025-09-04

LEFT-PANC

Helsinki University Central Hospital

Phase 3 Not yet recruiting

Gastrointestinal

Pancreatic Cancer Resectable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡